Modulim

About Modulim

Modulim is a medical technology company focused on advancing preventative care for patients with potential circulatory compromise. The company's origins trace back to the founder's graduate research at the University of California, Irvine. David J. Cuccia, Ph.D., founded the company, initially known as Modulated Imaging, in 2002 based on his doctoral dissertation work which resulted in the invention of its core technology, Spatial Frequency Domain Imaging (SFDI). While a student, Cuccia recognized the commercial potential of his research and, rather than licensing the technology, established the company himself. He was soon joined by Amaan Mazhar, Ph.D., who has been instrumental in the company's research and development efforts since 2011 and now serves as Chief Product Officer.

Modulim's business is centered on the development and sale of optical imaging systems for the healthcare market, particularly in the field of wound care and vascular assessment. The company targets clinicians, hospitals, and specialized care centers, such as dialysis and vascular access centers, that manage patients at high risk for lower-limb complications, including those with diabetes, kidney disease, and peripheral arterial disease (PAD). Its revenue model is based on the sale of its FDA-cleared Clarifi® Imaging System, which is supported by a Current Procedural Terminology (CPT) code, allowing for reimbursement from payers like Medicare. This is supplemented by the Modulim Cloud, a HIPAA-compliant platform for data storage and sharing to facilitate coordinated patient care.

The company's flagship product, the Clarifi® Imaging System, is a non-contact, noninvasive diagnostic tool that uses SFDI technology to see below the skin's surface. By projecting patterns of light and analyzing their reflection and absorption, the system can quantify and map five key biomarkers of tissue health, specifically related to microvascular oxygenation and perfusion, in a matter of seconds. This provides clinicians with objective, actionable data to detect circulatory issues before they become critical, helping to prevent complications like diabetic foot ulcers and subsequent amputations. A key differentiator is its ability to provide a wide-field view of tissue health without exposing patients to radiation. Modulim has also developed the Limb Assessment, Management, and Preservation (LAMP) solution, which integrates the Clarifi system and Modulim Cloud into clinical workflows to improve patient management.